Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Tech-enabled 'anti-CRO' running end-to-end clinical trials on its own integrated eClinical platform with fixed-price delivery.
Lindus Health, founded in 2021 and headquartered in London, United Kingdom, positions itself as an 'anti-CRO' — running end-to-end clinical trials on Citrus, its own integrated eClinical platform spanning EDC, ePRO, eConsent, and recruitment, with fixed-price, milestone-based contracts. The company raised a $55M Series B led by Balderton Capital in January 2025 and also operates a US office in New York. Atlas found no vendor-held security certifications documented on its site.
50% — Partial coverage. Coverage score — how completely Atlas documents Lindus Health across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Large Pharma, Clinical Operations, R&D Leadership
Digital/Decentralized Trials, Patient Recruitment & Enrollment
Series B, Founded 2021
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?